Haupt Pharma Muenster GmbH

Form 483 issued July 6, 2018 · Muenster, Germany

Inspection
Jul 2 – Jul 6, 2018
Investigator
Doan T. Nguyen
Observations
3
Pages
4
FEI number
3006010798

In short: On July 6, 2018, FDA issued a Form 483 with 3 observations to Haupt Pharma Muenster GmbH in Muenster, Germany (FEI 3006010798) after an inspection that ran Jul 2 – Jul 6, 2018. The investigator was Doan T. Nguyen. Most observations concern quality system and facilities & equipment.

At a glance

Quality system and facilities & equipment account for 2 of 3 observations.

Quality system1
Facilities & equipment1
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit are not in…

  2. 02

    Appropriate controls are not exercised over computers or related systems to assure that changes in master…

  3. 03

    There are no written procedures for production and process controls designed to assure that the drug…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Haupt Pharma Muenster GmbH?

FDA listed 3 observations on this Form 483, mostly about quality system, facilities & equipment and production. The opening words of each observation are shown on this page.

Who inspected Haupt Pharma Muenster GmbH?

Doan T. Nguyen is named on this Form 483, for the inspection of Jul 2 – Jul 6, 2018. Each investigator has a profile showing what they cite most.

When was Haupt Pharma Muenster GmbH inspected by FDA?

The inspection ran Jul 2 – Jul 6, 2018, and the Form 483 is dated July 6, 2018.

How do I get the full Form 483 for Haupt Pharma Muenster GmbH?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free